Patents Assigned to Cross Bay, LLC
  • Composition and method for reducing blood glucose
    Patent number: 6884420
    Abstract: A composition for reducing blood sugar in humans in need thereof, contains Agaricus blazeii, alpha lipoic acid, transfer factor, polymannose, fenugreek, coenzyme Q-10, selenium, zinc, vitamin C, vitamin E, chromium and vanadium.
    Type: Grant
    Filed: May 19, 2003
    Date of Patent: April 26, 2005
    Assignee: Cross Bay, LLC
    Inventor: Darryl See
  • Composition and method for reducing blood glucose
    Publication number: 20040234513
    Abstract: A composition for reducing blood sugar in humans in need thereof, contains Agaricus blazeii, alpha lipoic acid, transfer factor, polymannose, fenugreek, coenzyme Q-10, selenium, zinc, vitamin C, vitamin E, chromium and vanadium.
    Type: Application
    Filed: May 19, 2003
    Publication date: November 25, 2004
    Applicant: Cross Bay, LLC
    Inventor: Darryl See
  • Method and composition for topical treatment of viral lesions
    Patent number: 6368637
    Abstract: A process for treating active viral lesions, such as herpes lesions and warts, on persons or animals, in which an active lesion containing a virus is scrubbed or debrided, an aqueous reagent solution containing neutral red and free chlorine is applied to the scrubbed lesion, and the lesion to which the reagent has been applied is exposed to ultraviolet light for a period sufficient to cause viral destruction. The invention further relates to the aqueous reagent solution containing neutral red and free chlorine.
    Type: Grant
    Filed: April 9, 2001
    Date of Patent: April 9, 2002
    Assignee: Cross Bay LLC
    Inventor: Jon Stoneburner